1. 408OSitravatinib demonstrates activity in patients with novel genetic alterations that inactivate CBL. (23rd October 2018) Authors: Bazhenova, L; Carvajal, R D; Cho, B C; Eaton, K; Goel, S; Heist, R S; Ingham, M; Wang, D; Werner, T; Neuteboom, S; Potvin, D; Chen, I; Christensen, J; Chao, R; Alva, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). (25th October 2017) Authors: Bamias, A; Tzannis, K; Harshman, L C; Crabb, S J; Wong, Y -N; Kumar Pal, S; De Giorgi, U; Ladoire, S; Agarwal, N; Yu, E Y; Niegisch, G; Necchi, A; Sternberg, C N; Srinivas, S; Alva, A; Vaishampayan, U; Cerbone, L; Liontos, M; Rosenberg, J; Powles, T Journal: Annals of oncology Issue: Volume 29:Number 2(2018) Page Start: 361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC). (13th August 2019) Authors: Bamias, A; Tzannis, K; Harshman, L C; Crabb, S J; Wong, Y -N; Kumar Pal, S; De Giorgi, U; Ladoire, S; Agarwal, N; Yu, E Y; Niegisch, G; Necchi, A; Sternberg, C N; Srinivas, S; Alva, A; Vaishampayan, U; Cerbone, L; Liontos, M; Rosenberg, J; Powles, T Journal: Annals of oncology Issue: Volume 30:Number 11(2019) Page Start: 1841 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗